Koninklijke Philips NVRYLPF 73 Net Margin % is 3.87% as of Mar. 2026, which is 40% below its 10-year median of 6.42. GuruFocus rates RYLPF with a GF Score™ of 73/100 and a GF Value™ of $25.13 (Fairly Valued). The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Koninklijke Philips NV ranks better than 60.34% on this metric.
The historical rank and industry rank for Koninklijke Philips NV's Net Margin % or its related term are showing as below:
RYLPF'
s Net Margin % Range Over the Past 10 Years
Min: -9.02 Med: 6.42 Max: 19.35
Current: 5.5
RYLPF's Net Margin % is ranked better than 60.34% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs RYLPF: 5.50
Koninklijke Philips NV (OTCPK:RYLPF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Koninklijke Philips NV Net Margin % Related Terms
Koninklijke Philips NV Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Koninklijke Philips NV's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Net Margin % distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Koninklijke Philips NV (RYLPF) has a Net Margin % of 3.87% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Koninklijke Philips NV and its competitors. This is 40% below median its historical median of 6.42. According to the industry distribution chart, Koninklijke Philips NV ranks #324 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 39.7%.
Is Koninklijke Philips NV's Net Margin % too high?
Koninklijke Philips NV's current Net Margin % of 3.87% is 40% below median its 10-year median of 6.42. The Medical Devices & Instruments industry median Net Margin % is 2.07. Koninklijke Philips NV's value of 3.87% is 87% above this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #324 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Koninklijke Philips NV has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #324 out of 817 companies for Net Margin %. This puts Koninklijke Philips NV in the upper half of its industry. The industry median Net Margin % is 2.07. Koninklijke Philips NV's value of 3.87% is 87% above this benchmark. While the company's 10-year median is 6.42 vs. the industry median of 2.07, Koninklijke Philips NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current Net Margin % of 3.87% is 87% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current Net Margin % is 3.87%, which is 40% below median its own 10-year median of 6.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.13, compared to a current price of $26.19 — trading 4.2% above its estimated fair value. The current Net Margin % is 3.87%, which is 40% below median its 10-year median of 6.42 and 87% above the Medical Devices & Instruments industry median of 2.07. Koninklijke Philips NV's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Net Margin % is 3.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued.
The current stock price of $26.19 is trading 4.2% above its estimated GF Value™ of $25.13.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for RYLPF:
Net Margin %: 3.87% (40% below median its 10-year median of 6.42)
GF Value™: $25.13 vs. price of $26.19 (4.2% above fair value)
Industry Position: 87% above the Medical Devices & Instruments median (#324 of 817)
No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
73GF Score
Get the complete analysis for RYLPF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYLPF has been successfully added to your 
